PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Molecular Modeling and Simulation, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria.\', \'Institute of Plant Biotechnology and Cell Biology, Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria.\', \'Institute of Molecular Biotechnology, Department of Biotechnology and Core Facility Biomolecular & Cellular Analysis, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria.\', \'Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.\', \'Institute of Biochemistry, Department of Chemistry, University of Natural Resources and Life Sciences, Vienna, Austria.\', \'Karolinska Institute, Department of Laboratory Medicine, Stockholm, Sweden.\', \'Apeiron Biologics, Vienna, Austria.\', \'National Veterinary Institute, Uppsala, Sweden.\', \'IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Dr. Bohr, Vienna, Austria.\', \'Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7554/eLife.73641e73641
?:hasPublicationType
?:journal
  • eLife
is ?:pmid of
?:pmid
?:pmid
  • 34927585
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.121
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all